Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Incannex Healthcare Inc ADR (IXHL)

Incannex Healthcare Inc ADR (IXHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Incannex Healthcare Inc ADR Suite 105 8 Century Circuit Norwest NS 2153 AUS

www.incannex.com Employees: 9 P: 61-4-0984-0786

Description:

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Key Statistics

Overview:

Market Capitalization, $K 31,757
Enterprise Value, $K 25,897
Shares Outstanding, K 17,643
Annual Sales, $ 10 K
Annual Net Income, $ -18,460 K
Last Quarter Sales, $ 70 K
Last Quarter Net Income, $ -5,420 K
EBIT, $ -31,410 K
EBITDA, $ -31,310 K
60-Month Beta 7.68
% of Insider Shareholders 26.53%
% of Institutional Shareholders 0.43%
Float, K 12,962
% Float 73.47%
Short Volume Ratio 0.46

Growth:

1-Year Return -60.65%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/14/24
Next Earnings Date 02/12/25
Earnings Per Share ttm -1.39
EPS Growth vs. Prev Qtr 25.64%
EPS Growth vs. Prev Year -185.31%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IXHL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -182.23%
Return-on-Assets % -127.38%
Profit Margin % -184,600.00%
Debt/Equity 0.00
Price/Sales 2,572.94
Price/Cash Flow N/A
Price/Book 4.49
Book Value/Share 0.37
Interest Coverage -0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar